John G Ullman & Associates Inc. Makes New Investment in Avantor, Inc. (NYSE:AVTR)

John G Ullman & Associates Inc. purchased a new position in shares of Avantor, Inc. (NYSE:AVTR - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 72,000 shares of the company's stock, valued at approximately $1,863,000.

A number of other hedge funds have also added to or reduced their stakes in AVTR. Boston Partners boosted its holdings in shares of Avantor by 2.2% in the 1st quarter. Boston Partners now owns 28,561,802 shares of the company's stock valued at $729,298,000 after purchasing an additional 624,369 shares in the last quarter. Canada Pension Plan Investment Board boosted its stake in Avantor by 6.8% in the second quarter. Canada Pension Plan Investment Board now owns 22,927,325 shares of the company's stock valued at $486,059,000 after buying an additional 1,463,695 shares in the last quarter. 1832 Asset Management L.P. grew its position in Avantor by 1,634.9% in the second quarter. 1832 Asset Management L.P. now owns 8,530,118 shares of the company's stock valued at $180,839,000 after acquiring an additional 8,038,451 shares during the last quarter. Robeco Schweiz AG raised its stake in Avantor by 5.0% during the second quarter. Robeco Schweiz AG now owns 6,006,985 shares of the company's stock worth $127,348,000 after acquiring an additional 287,717 shares in the last quarter. Finally, CCLA Investment Management lifted its holdings in shares of Avantor by 8.7% in the second quarter. CCLA Investment Management now owns 5,128,504 shares of the company's stock worth $109,624,000 after acquiring an additional 408,360 shares during the last quarter. 95.08% of the stock is owned by institutional investors.

Insider Activity

In other news, CAO Steven W. Eck sold 3,525 shares of Avantor stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $25.06, for a total value of $88,336.50. Following the completion of the sale, the chief accounting officer now owns 29,544 shares in the company, valued at $740,372.64. The trade was a 10.66 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 1.50% of the stock is owned by company insiders.

Avantor Trading Up 1.1 %

NYSE AVTR traded up $0.22 during mid-day trading on Thursday, reaching $20.36. 6,278,391 shares of the stock were exchanged, compared to its average volume of 6,497,570. The stock has a market cap of $13.86 billion, a P/E ratio of 43.78, a P/E/G ratio of 2.39 and a beta of 1.35. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06. Avantor, Inc. has a one year low of $19.59 and a one year high of $28.00. The stock has a 50 day simple moving average of $24.14 and a 200-day simple moving average of $23.91.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the stock. TD Cowen lifted their price target on shares of Avantor from $28.00 to $31.00 and gave the company a "buy" rating in a report on Monday, July 29th. Barclays decreased their target price on shares of Avantor from $28.00 to $25.00 and set an "overweight" rating on the stock in a research note on Friday, October 25th. Robert W. Baird dropped their price target on Avantor from $27.00 to $26.00 and set an "outperform" rating for the company in a research note on Monday, October 28th. Wells Fargo & Company reduced their price objective on Avantor from $30.00 to $28.00 and set an "overweight" rating on the stock in a research report on Monday, October 28th. Finally, Morgan Stanley upped their target price on Avantor from $28.00 to $29.00 and gave the stock an "overweight" rating in a report on Monday, July 29th. Three investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $27.57.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.